Table 4

Treatment of breast events.

Outcome

Studies

Participants

Risk Ratio (M-H, Fixed, 95% CI), I2


Tamoxifen (20 mg daily) versus anastrozole (1 mg daily)

Treatment of breast events

• at 3 months

Saltzstein 2005

90

0.38 (0.25, 0.58), -


Tamoxifen (10 mg daily) versus radiotherapy

Treatment of gynecomastia/breast pain/or both

• after 9 months

Perdona 2005

35

0.21 (0.05, 0.83), -


Kunath et al. BMC Medicine 2012 10:96   doi:10.1186/1741-7015-10-96

Open Data